Johnson & Johnson’s CalciMedica CALC Stock Holding History

Johnson & Johnson’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,539	Closed	-$25K	–	24
2022 Q4	$25K	Hold	3,539	–	–	0.01%	22
2022 Q3	$47K	Hold	3,539	–	–	0.01%	21
2022 Q2	$54K	Hold	3,539	–	–	0.01%	22
2022 Q1	$61K	Hold	3,539	–	–	0.01%	21
2021 Q4	$91K	Hold	3,539	–	–	0.01%	23
2021 Q3	$164K	Buy	+3,539	New	+$199K	0.01%	25

Johnson & Johnson's CALC Position: Q1 2023 in Review

Johnson & Johnson sold out of CalciMedica (CALC) in Q1 2023, closing a stake of 3,539 shares — an estimated $25K sold.

Johnson & Johnson first reported a position in CALC in Q3 2021 and held it in 6 quarters. The position peaked at $164K in Q3 2021. 0 funds tracked by Wall St. Rank hold CALC as of Q1 2023.

Johnson & Johnson reported no remaining CalciMedica position as of Q1 2023 after selling out during the quarter.
Johnson & Johnson sold 3,539 CalciMedica shares in Q1 2023, an estimated $25K.
Johnson & Johnson first reported a position in CalciMedica in Q3 2021 and held it in 6 quarters.
Johnson & Johnson's CalciMedica position peaked at $164K in Q3 2021.
0 funds tracked by Wall St. Rank held CalciMedica as of Q1 2023.

Based on Johnson & Johnson's 13F filing for Q1 2023, filed 11 May 2023.